Supplementary Table S1 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions

Lena Rai; Antonella Ravaggi; Eliana Bignotti; Robert L. Hollis; Dale W. Garsed; Ahwan Pandey; Kyriaki Barbara Papalois; FD Patel; Yasmin Kamel; Leticia Campo; Alistair Easton; Joel Nulsen; Breeshey Roskams-Hieter; Mara Artibani; Lili Wang; Nosheen Hussain; Luyao Wang; Nancy Zaarour; Aneesh Aggarwal; Amro Ahmed-Ebbiary; Aws Al-Deka; Michael Churchman; C. Simon Herrington; Laura Ardighieri; Federico Ferrari; Christopher Yau; Charlie Gourley; Franco Edoardo Odicino; Ahmed Ashour Ahmed

doi:10.1158/1078-0432.31006851

Supplementary Table S1 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions

2026 Open access

Read full text

Authors: Lena Rai, Antonella Ravaggi, Eliana Bignotti, Robert L. Hollis, Dale W. Garsed, Ahwan Pandey, Kyriaki Barbara Papalois, FD Patel, Yasmin Kamel, Leticia Campo, Alistair Easton, Joel Nulsen

+17 more

Breeshey Roskams-Hieter, Mara Artibani, Lili Wang, Nosheen Hussain, Luyao Wang, Nancy Zaarour, Aneesh Aggarwal, Amro Ahmed-Ebbiary, Aws Al-Deka, Michael Churchman, C. Simon Herrington, Laura Ardighieri, Federico Ferrari, Christopher Yau, Charlie Gourley, Franco Edoardo Odicino, Ahmed Ashour Ahmed

DOI: 10.1158/1078-0432.31006851

Cited by: 0

Abstract

Supplementary Table S1. [Worksheet-1] List of differentially expressed genes in OxC-EMT-high compared to OxC-EMT-low bulk tumour samples from patients in the Brescia, TCGA, AOCS and OVCAD cohorts. [Worksheet-2] List of differentially expressed genes in OxC-EMT-high compared to OxC-EMT-low tumour epithelial cells.

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Ferroptosis and cancer prognosis

Publication details

Publication date: 6 January 2026